The 2nd Global Congress on Cardiology, Diabetes & Endocrinology, organized by Vartus Group, will be held on March 27–28, 2026 in Singapore City, Singapore. This prestigious global event unites leading experts, clinicians, researchers, and industry innovators from around the world to explore the latest advancements in cardiovascular medicine, endocrinology, and diabetes research.

The congress features high-impact keynote lectures, interactive panel discussions, hands-on workshops, and case-based sessions covering heart disease, metabolic disorders, hormonal imbalances, diabetes complications, and cutting-edge technologies including precision medicine, AI-driven diagnostics, and digital therapeutic tools.

In addition to scientific enrichment, the congress provides an exceptional platform for building collaborations, fostering innovation, and exchanging breakthrough ideas that shape the future of cardiometabolic health. Participants will also gain insights into global healthcare challenges, new clinical guidelines, emerging treatment strategies, and transformative research trends.

This event is not affiliated with Invest Ottawa and is independently organized by a third party.